Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

255.97 USD +0.26 (+0.10%)
Official Closing Price Updated: 7:15 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
79 80 Next >
Thinking about trading options or stock in Exxon Mobil Corporation, United Airlines, salesforce.com, Amgen, Inc., or Tortoise Acquisition Corp Class A?
InvestorsObserver issues critical PriceWatch Alerts for XOM, UAL, CRM, AMGN, and SHLL. 
From PR Newswire
Salesforce.com, Amgen and Honeywell International Set to Join Dow Jones Industrial Average
S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) effective prior to the opening of trading on Monday, August 31: 
From PR Newswire
Ligand Announces Amgen’s KYPROLIS® Approved by FDA as Combination Regimen with DARZALEX® and Dexamethasone in Once- and Twice-Weekly Dosing Regimens for Patients with Relapsed/Refractory Multiple Myel
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that a major Captisol customer Amgen (NASDAQ: AMGN) has received U.S. Food and Drug Administration (FDA) approval for the expansion of the... 
From Business Wire News Releases
FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens
Approval Based on the CANDOR and EQUULEUS Studies in Patients With Relapsed/Refractory Multiple Myeloma 
From PR Newswire
Amgen Announces Pricing Terms For Senior Notes Exchange Offers, Increases The Maximum Notes Exchange Cap And Accepts Tendered Notes
Amgen Inc. (NASDAQ:AMGN) announced today the pricing terms of its previously announced nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers")... 
From PR Newswire
Amgen Announces Early Tender Results Of Senior Notes Exchange Offers
Amgen Inc. (NASDAQ:AMGN) announced today the early tender results of its previously announced nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange... 
From PR Newswire
Dietary cholesterol and phytosterols contribute directly to heart disease
Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk 
From PR Newswire
Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates
Moderna reports second quarter 2020 financial results and provides business updates. 
From Business Wire News Releases
Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial
- I-SPY COVID will evaluate the impact of cenicriviroc, Otezla®, and Firazyr® on inflammatory response in COVID-19 patients 
From PR Newswire
Amgen Commences Exchange Offers For Certain Series Of Outstanding Senior Notes From Exchange Eligible Holders
Amgen Inc. (NASDAQ: AMGN) announced today the commencement of nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") certain specified series of... 
From PR Newswire
Amgen Reports Second Quarter 2020 Financial Results
Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2020. 
From PR Newswire
Amgen Announces Webcast Of 2020 Second Quarter Financial Results
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S. financial markets. The announcement will be followed... 
From PR Newswire
Amgen Announces 2020 Third Quarter Dividend
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the third quarter of 2020. The dividend will be paid on September 8, 2020, to all stockholders of... 
From PR Newswire
Amgen Appoints Amy E. Miles To Board Of Directors
Amgen today announced the appointment of Amy E. Miles to its Board of Directors, effective July 23, 2020. Ms. Miles will serve as a member of the Board's Audit Committee and Governance and Nominating... 
From PR Newswire
Amgen Foundation Awards Khan Academy An Additional $3 Million To Support Science Learning And Educational Equity Amid COVID-19
Foundation Expands Five-Year Relationship to Include Support for School Districts Facing Deep Budget Cuts 
From PR Newswire
Amgen Announces Additional Investment In BeiGene
Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's current pro rata ownership... 
From PR Newswire
Appeals Court Affirms Validity Of Enbrel® (etanercept) Patents Injunction Against Sandoz's Infringement Stands
Amgen today announced that the United States Court of Appeals for the Federal Circuit has held in Amgen's favor on the validity of two patents that describe and claim Enbrel® (etanercept) and methods... 
From PR Newswire
deCODE Genetics: Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseases
The combination of genomics, transcriptomics and proteomics sheds light on autoimmune thyroid disease, other autoimmune diseases and AML 
From PR Newswire
Launch of EIU report showing lack of integrated follow up care can increase risk of subsequent heart attack or stroke in APAC economies
From ACN Newswire
Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries
Amgen (NASDAQ: AMGN) today announced it is supporting the further study of AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor, for the treatment of tuberculosis (TB) and erythema nodosum leprosum... 
From PR Newswire
Amgen To Present At The BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference at 4:00 p.m. ET on Tuesday, June 23, 2020. Elliott Levy, senior vice president of R&D... 
From PR Newswire
Ray Jordan Joins Moderna as Chief Corporate Affairs Officer
Ray Jordan joins Moderna as Chief Corporate Affairs Officer. 
From Business Wire News Releases
Amgen To Present At The Goldman Sachs 41st Annual Global Healthcare Conference
Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 41st Annual Virtual Global Healthcare Conference on Wednesday, June 10, 2020 at 1:20 p.m. ET. Peter H. Griffith, executive vice president and chief... 
From PR Newswire
David Meline Joins Moderna as Chief Financial Officer
David Meline joins Moderna as Chief Financial Officer. 
From Business Wire News Releases
Amgen Presents New AMG 510 Clinical Data Across Multiple Solid Tumors During ASCO20 Virtual Scientific Program
Data in Advanced Colorectal Cancer Show Disease Control Rate of 80% at Target Dose 
From PR Newswire
Amgen To Present At The Jefferies 2020 Virtual Healthcare Conference
Amgen (NASDAQ: AMGN) will present at the Jefferies 2020 Virtual Healthcare Conference at 4:00 p.m. ET on Tuesday, June 2, 2020. David M. Reese, M.D., executive vice president of Research and... 
From PR Newswire
Amgen To Webcast Investor Meeting At 56th Annual Meeting Of The American Society Of Clinical Oncology (ASCO)
Amgen (NASDAQ: AMGN) will host a webcast call for the investment community in conjunction with the ASCO20 Virtual Scientific Program on Friday, May 29, at 1:00 p.m. PT. David M. Reese, M.D., executive... 
From PR Newswire
Amgen Announces Voting Results Of Annual Meeting Of Stockholders
Amgen (NASDAQ:AMGN) today announced voting results from the Company's Annual Meeting of Stockholders on May 20, 2020, held virtually this year due to the COVID-19 pandemic. More than 88 percent of... 
From PR Newswire
Amgen Showcases Oncology Pipeline At ASCO 2020
Updated Data Evaluating Sotorasib (AMG 510), a First-in-Class Investigational KRASG12C Inhibitor, in Colorectal Cancer and Other Solid Tumors 
From PR Newswire
Amgen To Present At The Bank Of America Merrill Lynch Virtual Global Healthcare Conference
Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference at 1:40 p.m. ET on Thursday, May 14. Peter H. Griffith, executive vice president and chief... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
79 80 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.